日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

瑞波替尼治疗NTRK融合阳性晚期实体瘤:一项1/2期试验

Besse, Benjamin; Lin, Jessica J; Bazhenova, Lyudmila; Goto, Koichi; de Langen, Adrianus Johannes; Kim, Dong-Wan; Wolf, Jürgen; Springfeld, Christoph; Popat, Sanjay; Lim, Darren W T; Nagasaka, Misako; Hong, Jung Yong; Baik, Christina S; Hervieu, Alice; Moreno, Victor; Yang, Nong; Kollengode, Kanthi; Yang, Haisu; Xu, Yuanfang; Calvet, Christophe Y; Yuan, Yong; Hammell, Amy B; Drilon, Alexander; Solomon, Benjamin J

Expert consensus on the detection and clinical application of tumor mutational burden

关于肿瘤突变负荷的检测和临床应用的专家共识

Guo, Zhenying; Xu, Chunwei; Zhang, Shirong; Hao, Yue; Hu, Xiaotong; Zhao, Ming; Xiang, Chan; Piao, Yingshi; Sun, Pingli; Xiang, Xueping; Zhao, Jing; Wu, Huanwen; Li, Weixing; Yu, Jinpu; Yuan, Jingping; Wang, Shuangshuang; Wang, Cong; Gu, Yun; Lv, Bingjian; Zhang, Liping; Liu, Yueping; Cui, Xiaobin; Gu, Weizhong; Li, Yining; Wang, Wei; Yang, Wenjun; Long, Weiguo; Xiang, Jingjing; Mou, Hong; Liu, Biao; Ruan, Huajuan; Wang, Yubin; Zhu, Yongjie; Wang, Feng; Wang, Zhonghua; Feng, Xiaomin; Liu, Xing; Li, Peng; Deng, Min; Lian, Bin; Mao, Lili; Wang, Qian; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Zhong, Wenzhao; Wang, Zhijie; Ren, Shengxiang; Fang, Wenfeng; Zhang, Yongchang; Liu, Jingjing; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Zhang, Yu; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Shen, Peng; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Ge, Rui; Dai, Enyong; Han, Yu; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Liu, Xuewen; Yao, Yu; Luo, Peng; Pan, Weiwei; Pang, Fei; Wu, Fan; Gu, Dejian; Wang, Li; Wang, Liping; Zhu, Youcai; Lin, Li; Li, Weiwen; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Ji, Qing; Fang, Yuan; Wei, Qing; Wang, Zhen; Wan, Bin; Lv, Donglai; Li, Xiaofeng; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Zhongwu; Li, Miao; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Si, Lu; Song, Yong; Lu, Yuanzhi; Liu, Aijun; Han, Yuchen

International guidelines on the diagnosis and treatment of NUT carcinoma

关于NUT癌诊断和治疗的国际指南

Zhang, Yu; Zhang, Qi; Hao, Yue; Luo, Jia; Piao, Yingshi; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Brcic, Luka; Liu, Aijun; Yu, Jinpu; Tsutani, Yasuhiro; Zhong, Wenzhao; Fang, Wenfeng; Wang, Zhijie; Ren, Shengxiang; Papavassiliou, Athanasios G; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Cangir, Ayten Kayi; Liu, Anwen; Li, Wen; Lococo, Filippo; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Popper, Helmut; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Kairemo, Kalevi; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Leanne, Ashrafian; Li, Xiaoyan; Tang, Chuanhao; Siddique, Hifzur R; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Shelat, Vishal; Guo, Hui; Chu, Qian; Meng, Rui; Ardeshir, Fatemeh; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Kratzke, Robert A; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Calabrese, Fiorella; Xia, Yang; Mariani, Alessandro Wasum; Lu, Yuanyuan; Chen, Xiaofeng; Klein, Mark A; Ge, Rui; Dai, Enyong; Schönthal, Axel H; Han, Yu; Guo, Zhenying; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Chiappetta, Marco; Liu, Xuewen; Salle, Francoise Galateau; Yao, Yu; Szolkowska, Malgorzata; Pan, Weiwei; Pang, Fei; Wu, Fan; Watzka, Stefan B; Wang, Liping; Zhu, Youcai; Lin, Li; Sharma, Aparna; Tu, Jianfei; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Zauderer, Marjorie G; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Dudnik, Elizabeth; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Feng, Yue; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Baine, Marina K; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Wu, Jing; Yang, Yunyun; Fang, Yuan; Wang, Zhen; Wan, Bin; Lv, Donglai; Chen, Huafei; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Sobeih, Mohamed Emam; Li, Bihui; Lian, Bin; Mao, Lili; Zhang, Zhang; Wang, Ke; Li, Zhongwu; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Miao; Wang, Guansong; Marron, Thomas U; Wang, Jiandong; Popat, Sanjay; Fang, Meiyu; Fang, Yong; Mansilla, Daniel; Li, Yuan; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Mansfield, Aaron S; Wang, Biyun; Si, Lu; Roden, Anja C; Grønberg, Bjørn H; Song, Yong; Shapiro, Geoffrey I; French, Christopher A; Lu, Yuanzhi; Wang, Qian; Xu, Chunwei

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial

HA121-28 在晚期实体瘤和 RET 融合阳性非小细胞肺癌患者中的安全性、药代动力学和疗效:一项多中心、开放标签、单臂 1/2 期试验

Ruan, Dan-Yun; Huang, Wen-Wen; Li, Yongsheng; Zhao, Yanqiu; Shi, Yehui; Jia, Yuming; Cang, Shundong; Zhang, Wei; Shi, Jianhua; Chen, Jun; Lin, Jie; Liu, Yunpeng; Xu, Jianming; Ouyang, Weiwei; Fang, Jian; Zhuang, Wu; Liu, Caigang; Bu, Qing; Li, Manxiang; Meng, Xiangjiao; Sun, Meili; Yang, Nong; Dong, Xiaorong; Pan, Yueyin; Li, Xingya; Qu, Xiujuan; Zhang, Tongmei; Yuan, Xianglin; Hu, Sheng; Guo, Wei; Li, Yalun; Li, Shengqing; Liu, Dongying; Song, Feixue; Tan, Liping; Yu, Yan; Yu, Xinmin; Zang, Aimin; Sun, Chang; Zhang, Qian; Zou, Kai; Dan, Mo; Xu, Rui-Hua; Zhao, Hongyun

Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS(G12C) inhibitor-naïve Chinese patients with KRAS(G12C)-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies

IBI351(富泽拉西布)单药治疗KRAS(G12C)突变型转移性结直肠癌且既往未接受过KRAS(G12C)抑制剂治疗的中国患者的疗效和安全性:两项研究I期部分的汇总分析

Yuan, Ying; Deng, Yanhong; Jin, Yongdong; Guo, Zengqing; Pan, Yueyin; Wang, Cunji; Wang, Zhiwu; Hu, Yi; Hua, Dong; Meng, Xiangjiao; Zhang, Zhiye; Zhao, Mingfang; Dong, Xiaorong; Huang, Dingzhi; Li, Xiaoyan; Liu, Lian; Sun, Meili; Wang, Huijuan; Wang, Xiuwen; Yang, Nong; Zhang, Mingjun; Hu, Sheng; Wu, Dongde; Huang, Jingjing; Zhang, Sujie; Huang, Mengna; Ding, Kefeng

A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)

一项针对接受 EGFR-TKI 治疗后出现渐进性、寡转移性或潜在进展的晚期非小细胞肺癌患者的 II 期试验,评估安罗替尼联合 EGFR-TKI 的疗效 (CTONG-1803/ALTER-L001)

Chen, Hua-Jun; Tu, Hai-Yan; Hu, Yanping; Fan, Yun; Wu, Guowu; Cang, Shundong; Yang, Yi; Yang, Nong; Ma, Rui; Jin, Gaowa; Xu, Ximing; Liu, Anwen; Tang, Shubin; Cheng, Ying; Yu, Yan; Xu, Chong-Rui; Zhou, Qing; Wu, Yi-Long

PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.

PD-1/PD-L1 双特异性抗体 IBI318 与乐伐替尼联合治疗对免疫检查点抑制剂产生耐药性的晚期非小细胞肺癌:一项 II 期试验。

Zeng Liang, Ruan Zhaohui, Yan Huan, Qin Haoyue, Zeng Zhen, Zou Chun, Huang Zhe, Jiang Wenjuan, Dai Jiacheng, Xu Shidong, Song Lianxi, Chen Yangqian, Zhang Yuda, Zeng Fanxu, Wei Shiyou, Chen Shanmei, Liu Li, Xiong Yi, Wang Zhan, Deng Jun, Zhang Xing, Sun Yuanze, Yang Dan, Zhou Chunhua, Yang Haiyan, Li Yizhi, Deng Li, Xu Qinqin, Fang Chao, Chen Xue, Wang Jing, Li Ting, Zhang Gao, Zhou Hui, Yang Nong, Zhang Yongchang

Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study

根据联合免疫化疗治疗晚期非小细胞肺癌的时间安排,探讨总生存期:一项双中心双洲研究

Huang, Zhe; Karaboué, Abdoulaye; Zeng, Liang; Lecoeuvre, Adrien; Zhang, Lemeng; Li, Xiao-Mei; Qin, Haoyue; Danino, Gabrielle; Yang, Feng; Malin, Marie-Sara; Deng, Li; Rigal, Marte; Liu, Hong; Chen, Xiang; Xu, Qinqin; Grimaldi, Lamiae; Collon, Thierry; Wang, Jing; Adam, René; Yang, Nong; Duchemann, Boris; Zhang, Yongchang; Lévi, Francis

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration

关于MET改变的非小细胞肺癌的诊断和治疗的专家共识

Feng, Huijing; Xia, Yang; Wang, Wenxian; Xu, Chunwei; Wang, Qian; Song, Zhengbo; Li, Ziming; Yu, Jinpu; Zhong, Wenzhao; Wang, Zhijie; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lyu, Tangfeng; Miao, Liyun; Min, Lingfeng; Lin, Gen; Huang, Long; Yuan, Jingping; Jiang, Zhansheng; Pu, Xingxiang; Rao, Chuangzhou; Lyu, Dongqing; Yu, Zongyang; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Mei, Qi; Guo, Hui; Chu, Qian; Meng, Rui; Liu, Xuewen; Wu, Jingxun; Zhou, Jin; Zhu, Zhengfei; Pan, Weiwei; Pang, Fei; Hu, Meizhen; Wang, Kai; Wu, Fan; Xu, Bingwei; Xu, Ling; Wang, Liping; Zhu, Youcai; Li, Jisheng; Xie, Yanru; Lin, Xinqing; Cai, Jing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Gao, Wenbin; Huang, Jianhui; Zhang, Yinbin; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Hao, Yue; Wang, Zheng; Wan, Bing; Lyu, Donglai; Jiao, Xiaodong; Shi, Lin; Lan, Gang; Yang, Shengjie; Shang, Yanhong; Wang, Yina; Li, Bihui; Jin, Gang; Zheng, Kang; Ma, Jun; Li, Wenfeng; Zhang, Zhang; Li, Zhongwu; Li, Yuan; Liu, Zhefeng; Ma, Xuelei; Yang, Nong; Wu, Lin; Wang, Qiming; Wang, Guansong; Hong, Zhuan; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Zhu, Xixu; Shen, Yi; Wang, Ke; Ren, Xiubao; Zhang, Yiping; Ma, Shenglin; Zhang, Junping; Song, Yong; Fang, Wenfeng; Lu, Yuanzhi

Tumor immune microenvironment score predicts efficacy of immune checkpoint inhibitors-based regimens in advanced non-small cell lung cancer.

肿瘤免疫微环境评分可预测基于免疫检查点抑制剂的治疗方案对晚期非小细胞肺癌的疗效。

Dai Jiacheng, Yan Huan, Chen Yangqian, Zhang Yuda, Huang Zhe, Ruan Zhaohui, Tian Fang, Qin Haoyue, Xu Qinqin, Wang Jin, Li Xing, Cheng Peng, Zhu Changbin, Yang Nong, Zeng Liang, Zhang Yongchang